Transition Agreements in the Biotechnology Industry

127 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Transition Agreement between Incyte Corporation and Hervé Hoppenot (June 26, 2025)
Transition Agreements
Incyte
Biotechnology
NY
2025
Transition Agreement between Vor Biopharma Inc. and Robert Ang (June 25, 2025)
Transition Agreements
Vor Biopharma Inc.
Biotechnology
2025
Transition Agreement and Mutual General Release between Kronos Bio, Inc. and Genentech, Inc. and F. Hoffmann-La Roche Ltd
Transition Agreements
Kronos Bio, Inc.
Biotechnology
2025
Transition Agreement and Release between Tina Marriott and Recursion Pharmaceuticals, Inc.
Transition Agreements
RECURSION PHARMACEUTICALS, INC.
Biotechnology
UT
2025
Transition Services Agreement between Passage Bio, Inc. and Gemma Biotherapeutics, Inc. (July 31, 2024)
Transition Agreements
Passage BIO, Inc.
Biotechnology
PA
2024
Transition Agreement between Tyra Biosciences, Inc. and Hiroomi Tada, M.D., Ph.D.
Transition Agreements
Tyra Biosciences, Inc.
Biotechnology
CA
2024
Janux Therapeutics, Inc. Transition and Consulting Agreement with Tighe Reardon (August 2024)
Transition Agreements
Janux Therapeutics, Inc.
Biotechnology
CA
2024
Executive Transition Agreement between Acadia Pharmaceuticals Inc. and Stephen R. Davis
Transition Agreements
ACADIA PHARMACEUTICALS INC
Biotechnology
CA
2024
Transition Agreement between Karyopharm Therapeutics Inc. and Michael Mason (August 29, 2024)
Transition Agreements
Karyopharm Therapeutics Inc.
Biotechnology
MA
2024
Transition Agreement between Esperion Therapeutics, Inc. and JoAnne Foody, MD
Transition Agreements
Esperion Therapeutics, Inc.
Biotechnology
DE
2024
Separation and Transition Agreement between Cullinan Oncology, Inc. and Jeff Trigilio
Transition Agreements
Cullinan Oncology, LLC
Biotechnology
2024
Transition Agreement and Release between Shafique Virani and Recursion Pharmaceuticals, Inc.
Transition Agreements
RECURSION PHARMACEUTICALS, INC.
Biotechnology
FL
2024
Amended and Restated Transitional Services Agreement between 2seventy bio, Inc. and Nick Leschly
Transition Agreements
2seventy bio, Inc.
Biotechnology
MA
2024
Amended and Restated Transitional Services Agreement between 2seventy bio, Inc. and Nick Leschly
Transition Agreements
2seventy bio, Inc.
Biotechnology
MA
2024
Transition Services Agreement between Mural Oncology, Inc. and Alkermes, Inc. (November 13, 2023)
Transition Agreements
Alkermes plc.
Biotechnology
PA
2023
Retirement and Transition Agreement between Nancy Simonian and Syros Pharmaceuticals, Inc.
Transition Agreements
Syros Pharmaceuticals, Inc.
Biotechnology
MA
2023
Transition and Release Agreement between Aura Biosciences, Inc. and Dr. Cadmus Rich
Transition Agreements
Aura Biosciences, Inc.
Biotechnology
MA
2023
Transition Agreement between SQZ Biotechnologies Company and Marshelle Smith Warren (October 3, 2023)
Transition Agreements
SQZ Biotechnologies Co
Biotechnology
2023
Transition Agreement between SQZ Biotechnologies Company and Lawrence Knopf (October 2023)
Transition Agreements
SQZ Biotechnologies Co
Biotechnology
2023
Transition Agreement between SQZ Biotechnologies Company and Richard Capasso (October 2023)
Transition Agreements
SQZ Biotechnologies Co
Biotechnology
2023
Transition Agreement between SQZ Biotechnologies Company and Howard Bernstein, M.D., Ph.D. (October 3, 2023)
Transition Agreements
SQZ Biotechnologies Co
Biotechnology
2023
Transition Agreement between AbbVie Global Enterprises Ltd. and CytomX Therapeutics Inc.
Transition Agreements
CytomX Therapeutics, Inc.
Biotechnology
DE
2023
Transition and Consulting Agreement between Deciphera Pharmaceuticals, LLC and Daniel L. Flynn, Ph.D.
Transition Agreements
Deciphera Pharmaceuticals, Inc.
Biotechnology
MA
2023
Transition Services and Separation Agreement between AgeX Therapeutics, Inc. and Michael David West
Transition Agreements
AgeX Therapeutics, Inc.
Biotechnology
CA
2023
Retirement and Transition Agreement between Sera Prognostics, Inc. and Gregory C. Critchfield, M.D.
Transition Agreements
SERA PROGNOSTICS, INC.
Biotechnology
UT
2023
Amendment to Transition Services Agreement between Eisai Inc. and Catalyst Pharmaceuticals, Inc.
Transition Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
2023
DermTech, Inc. CEO Transition and Consulting Agreement with John Dobak, M.D.
Transition Agreements
Constellation Alpha Capital Corp.
Biotechnology
CA
2023
Transition Agreement between GlycoMimetics, Inc. and John Magnani, Ph.D.
Transition Agreements
GLYCOMIMETICS INC
Biotechnology
MD
2023
Amendment No. 1 to Executive Transition and Separation Agreement between Daniel Soland and Aceragen, Inc.
Transition Agreements
IDERA PHARMACEUTICALS, INC.
Biotechnology
PA
2023
Eliem Therapeutics, Inc. Transition, Separation, and Consulting Agreement with Erin M. Lavelle
Transition Agreements
Eliem Therapeutics, Inc.
Biotechnology
2023
Transition and Release Agreement between Fresh Tracks Therapeutics, Inc. and Robert B. Brown (February 2023)
Transition Agreements
VICAL INC
Biotechnology
2023
Transition Services Agreement between Eisai Inc. and Catalyst Pharmaceuticals, Inc.
Transition Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
DE
2022
Transition and General Release Agreement between Talaris Therapeutics, Inc. and Dr. Suzanne Ildstad
Transition Agreements
Talaris Therapeutics, Inc.
Biotechnology
DE
2022
Gain Therapeutics, Inc. and Eric I. Richman Transition Agreement Dated September 19, 2022
Transition Agreements
Gain Therapeutics, Inc.
Biotechnology
MD
2022
Cortexyme, Inc. Transition Separation Agreement with Caryn G. McDowell dated May 19, 2022
Transition Agreements
Cortexyme, Inc.
Biotechnology
CA
2022
Amendment to Transition Services Agreement between bluebird bio, Inc. and 2seventy bio, Inc.
Transition Agreements
bluebird bio, Inc.
Biotechnology
2022
Transition and Consulting Agreement between Praxis Precision Medicines, Inc. and Bernard Ravina
Transition Agreements
Praxis Precision Medicines, Inc.
Biotechnology
MA
2022
First Amendment to Transitional Services Agreement between Orchard Therapeutics plc, Orchard Therapeutics North America, and Frank Thomas
Transition Agreements
Orchard Therapeutics plc
Biotechnology
2022
Metacrine, Inc. Transition, Separation, and Consulting Agreement with Trisha Millican
Transition Agreements
Metacrine, Inc.
Biotechnology
CA
2022
Transition and Separation Agreement between CohBar, Inc. and Kenneth Cundy (January 5, 2022)
Transition Agreements
CohBar, Inc.
Biotechnology
CA
2022